Schizophrenia: genes and variants
Explore variant evidence for Schizophrenia across 8 analyzed proteins (MTHFR, DRD2, DRD3, DRD4, GRIN2A and 3 more). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-03. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Schizophrenia
MTHFR: Methylenetetrahydrofolate reductase (NADPH)
It generates 5-methyltetrahydrofolate for remethylation of homocysteine to methionine, linking folate metabolism with methyl-group supply. Severe biallelic deficiency causes homocystinuria with neurologic and thrombotic complications, while common variants produce much smaller effects on homocysteine.
2 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in MTHFR have source records linked to Schizophrenia. Association strength is not clinical gene validity.
DRD2: D(2) dopamine receptor
Its activation by dopamine modulates cyclic-AMP signaling and neuronal excitability in circuits governing movement, motivation, reward, and endocrine control. It is a major pharmacologic target of antipsychotic drugs and dopamine agonists, and rare variants can produce movement or neuropsychiatric phenotypes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DRD2 have source records linked to Schizophrenia. Association strength is not clinical gene validity.
DRD3: Dopamine receptor D3
It senses dopamine and signals mainly through inhibitory G proteins that reduce adenylyl cyclase activity. Enriched in limbic brain circuits, it helps regulate motivation, reward, emotion, and movement, making it a target of research into addiction and neuropsychiatric disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DRD3 have source records linked to Schizophrenia. Association strength is not clinical gene validity.
DRD4: D(4) dopamine receptor
It modulates dopamine signaling in cortical and limbic circuits and influences cyclic-AMP production and neuronal excitability. Common repeat polymorphisms have been studied extensively for behavioral traits, although their individual effects are modest and not deterministic.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DRD4 have source records linked to Schizophrenia. Association strength is not clinical gene validity.
GRIN2A: Glutamate receptor ionotropic, NMDA 2A
It helps determine the kinetics and signaling properties of NMDA receptors, particularly in cortical circuits involved in language and epilepsy. Pathogenic variants cause a spectrum of developmental epileptic encephalopathies and epilepsy-aphasia disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GRIN2A have source records linked to Schizophrenia. Association strength is not clinical gene validity.
HTR2A: 5-hydroxytryptamine receptor 2A
Its activation by serotonin engages Gq signaling in cortical, vascular, and other tissues and influences perception, mood, cognition, and smooth-muscle responses. It is a major target of many antipsychotic drugs and psychedelic compounds, while common genetic effects on behavior are generally modest.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HTR2A have source records linked to Schizophrenia. Association strength is not clinical gene validity.
HTR2C: 5-hydroxytryptamine receptor 2C
Its serotonin-dependent signaling in hypothalamic and limbic circuits suppresses appetite and modulates mood, reward, and neuroendocrine function. Altered signaling can affect body weight and psychiatric drug responses, and the receptor is a pharmacologic target of several neuropsychiatric agents.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HTR2C have source records linked to Schizophrenia. Association strength is not clinical gene validity.
OPRM1: Mu-type opioid receptor
A G protein-coupled receptor for endogenous opioids and medicines such as morphine and fentanyl. Its activation changes neuronal signaling involved in pain, reward, and respiratory control through inhibitory G protein pathways.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in OPRM1 have source records linked to Schizophrenia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): COMT and TH.
ClinVar pathogenic and likely pathogenic variants linked to Schizophrenia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MTHFR R68G | 68 | Pathogenic / likely pathogenic (★★) | |
| MTHFR L439P | 439 | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Homocystinuria due to methylene tetrahydrofolate reductase deficiency also has ClinVar records linked to MTHFR variants; they fall mostly in different places as the Schizophrenia variants (43 pathogenic / likely pathogenic).
- Neural tube defects, folate-sensitive also has ClinVar records linked to MTHFR variants; they fall mostly in different places as the Schizophrenia variants (19 pathogenic / likely pathogenic).
- Thrombophilia due to thrombin defect also has ClinVar records linked to MTHFR variants; they fall mostly in different places as the Schizophrenia variants (6 pathogenic / likely pathogenic).
Diseases related to Schizophrenia
- Parkinson disease, also linked to DRD2, DRD3, DRD4, GRIN2A and 2 more
- Autism, also linked to DRD2, HTR2A and HTR2C
- Alzheimer disease, also linked to GRIN2A
- Landau-Kleffner syndrome, also linked to GRIN2A
- Homocystinuria due to methylene tetrahydrofolate reductase deficiency, also linked to MTHFR
- Neural tube defects, folate-sensitive, also linked to MTHFR
- Epilepsy, also linked to GRIN2A
- Tremor, hereditary essential, also linked to DRD3
- Thrombophilia due to thrombin defect, also linked to MTHFR
- Rolandic epilepsy, also linked to GRIN2A
- Migraine, also linked to OPRM1
- Dementia, also linked to GRIN2A
Frequently asked questions
Which genes have records linked to Schizophrenia?
This view contains 8 analyzed proteins: MTHFR, DRD2, DRD3, DRD4, GRIN2A and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 28 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center